Cargando…
Angiogenesis and chronic kidney disease
The number of patients requiring renal replacement therapy due to end-stage renal disease (ESRD) is increasing worldwide. The prevalence of chronic kidney disease (CKD), and the importance of CKD as a risk factor in development of ESRD and in complicating cardiovascular disease (CVD) have been confi...
Autores principales: | Maeshima, Yohei, Makino, Hirofumi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924264/ https://www.ncbi.nlm.nih.gov/pubmed/20687922 http://dx.doi.org/10.1186/1755-1536-3-13 |
Ejemplares similares
-
Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
por: Nasu, Tatsuyo, et al.
Publicado: (2009) -
A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
por: Kitagawa, Masashi, et al.
Publicado: (2013) -
Serum High-Sensitivity Cardiac Troponin T Is a Significant Biomarker of Left-Ventricular Diastolic Dysfunction in Subjects with Non-Diabetic Chronic Kidney Disease
por: Kitagawa, Masashi, et al.
Publicado: (2011) -
Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study
por: Tsuchida-Nishiwaki, Mariko, et al.
Publicado: (2021) -
Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression
por: Townsend, Raymond R., et al.
Publicado: (2013)